Tag Archives: Cooper Collins

A Director at TherapeuticsMD (NASDAQ: TXMD) is Buying Shares

Today, a Director at TherapeuticsMD (TXMD – Research Report), Cooper Collins, bought shares of TXMD for $99.6K. This recent transaction increases Cooper Collins’ holding in the company by 83.33% to a total of $218.5K. In addition to Cooper Collins, one